Skip to search formSkip to main contentSkip to account menu

gosogliptin

A potent, selective and orally bioavailable, difluoropyrrolidine-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity.
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

PF-00734200

Broader (2)

PyrimidinesPyrrolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
Current treatment strategies for type 2 diabetes mellitus (T2DM) are based on using safe and effective hypoglycaemic agents for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)